The article highlights the role of implantable cardioverter defibrillators (ICDs) in the primary and secondary prevention of sudden cardiac death. It considers the results of multicenter studies comparing the efficacy of antiarrhythmic drugs and implantable devices in the primary and secondary prevention of sudden cardiac death, including that in patients with nonischemic cardiomyopathy and discusses quality of life in patients with ICDs.
The psychological impact of ICDs results in severe physical and psychosocial impairment. This study attempts to analyze patients’ perceptions on decision making, satisfaction, security and end of life (EOL) as well as explore the similarities and differences between primary and secondary prophylaxis groups.
Implantable cardioverter defibrillators in the prevention of sudden cardiac death
